Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan [Phase 2]
This update reports the completion of a Phase 2 controlled study of ONO-8025 (KRP-197) for overactive bladder in Japan.
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan [Phase 3]
A Phase 3 trial in Japan evaluating Ono Pharmaceutical's ONO-8025 (KRP-197) for overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-20Clinical Trial Update: Evaluating the Change of Overactive Bladder Symptoms in Women Post Pubovaginal Sling Procedure for Stress Incontinence [Phase 4]
This Phase 4 trial update assesses changes in overactive bladder symptoms in women after a pubovaginal sling procedure for stress urinary in…
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms [Phase 4]
A Phase 4 trial evaluating solifenacin for mitigation of ureteral stent–induced pain and lower urinary tract symptoms has completed, with re…
-
CLINICAL_TRIALS trial_result · 2012-08-20Clinical Trial Update: Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder [Phase 2]
Phase 2 study evaluating safety and efficacy of DR-3001 versus placebo in women with overactive bladder has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial [Phase 4]
Allergan completed the Phase 4 SMART-II trial of Sanctura (trospium chloride) for overactive bladder, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency [Phase 4]
Phase 4 trial evaluating the efficacy and safety of fesoterodine for symptoms of overactive bladder, including nocturnal urinary urgency; st…
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: The Long-term Efficacy of Electrical Pudendal Nerve Stimulation for the Urgency-Frequency Syndrome in Women
This completed clinical trial from the Shanghai Institute of Acupuncture, Moxibustion and Meridian evaluates the long-term efficacy of elect…
-
CLINICAL_TRIALS trial_result · 2012-07-19Clinical Trial Update: Urgent-SQ in Treatment of Overactive Bladder Syndrome: 9-yr Follow up
This document reports a 9-year follow-up of Urgent-SQ for the treatment of overactive bladder, focusing on long-term outcomes and safety.
-
CLINICAL_TRIALS trial_result · 2012-07-13Clinical Trial Update: A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder [Phase 1]
A Phase 1 randomized, placebo-controlled trial is evaluating the efficacy of propantheline to treat overactive bladder associated with HTLV-…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan).
Pfizer completed a long-term post-marketing safety investigation of tolterodine for overactive bladder; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)
Clinical trial update for tolterodine as part of a post-marketing commitment; study on overactive bladder completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2012-06-14Clinical Trial Update: Study of ONO-8539 in Patients With Overactive Bladder [Phase 2]
This entry reports the completion of a Phase 2 trial evaluating ONO-8539 in patients with overactive bladder.
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder [Phase 3]
This Phase 3 trial assesses the long-term safety and efficacy of imidafenacin in adults with overactive bladder; the study has been complete…
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Feasibility of "At-home" Titration of Solifenacin [Phase 4]
Phase 4 study evaluating the feasibility of at-home titration of solifenacin for overactive bladder; the trial was terminated and results we…
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: Solifenacin Succinate Versus Fesoterodine A Comparison Trial for Urgency Symptoms [NA]
This clinical trial compares solifenacin succinate with fesoterodine for urgency symptoms in overactive bladder. The status is unknown.
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: InterStim Therapy Programming Study [NA]
Completed clinical trial evaluating InterStim Therapy programming; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder [Phase 4]
A Phase 4 clinical trial comparing the efficacy and safety of imidafenacin versus fesoterodine in adults with overactive bladder.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: This Is An Open-Label Study To Evaluate Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive Bladder
An open-label study evaluating fesoterodine plus a patient support plan in patients with overactive bladder has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity [Phase 3]
Phase 3 trial evaluating propiverine hydrochloride for neurogenic detrusor overactivity has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-02Clinical Trial Update: MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence. [Phase 2]
A Phase 2 randomized, placebo-controlled trial evaluating the safety and efficacy of SSR240600C in adults with overactive bladder has comple…
-
CLINICAL_TRIALS trial_result · 2012-01-25Clinical Trial Update: Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder [Phase 3]
Phase 3 trial update for Propiverine Hydrochloride Extended-Release Capsule in Overactive Bladder; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: Bryophyllum Versus Placebo for Overactive Bladder [Phase 2]
The Phase 2 trial evaluating Bryophyllum versus placebo for overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-09Clinical Trial Update: This Is A Study Of Bioavailability And Food Effect For Fesoterodine. [Phase 1]
Pfizer conducted a Phase 1 study to assess the bioavailability of fesoterodine and the effect of food on its pharmacokinetics in adults with…
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial [Phase 4]
The SMART Phase 4 trial of Sanctura (trospium chloride) assessing pharmacokinetics in elderly participants has completed, with results poste…